Study:
Neuropathic leg ulcers (NLUs) affect more than 10% of diabetic patients with peripheral neuropathy and represent the most common cause of ulceration of the leg in these patients. Vulnamin® gel could improve the outcomes of NLUs when used together with elastocompression.
Design:
- Thirty patients affected by NLU
- Randomized into 2 groups, both treated with 4-layer elastocompressive bandaging: group A were topically treated with the application of Vulnamin® gel, group B received only the inert gel vehicle.
Measurements:
- Healing rate at 3 months was evaluated as the primary endpoint.
- Healing time, reduction in ulcer area and ulceration score in 4 weeks.
- Number of infective complications, and overall satisfaction of
patients.
Efficacy and safety of a new dressing gel in the treatment of diabetic patients suffering from neuropathic ulcer lower limbs: prospective randomized double-blind trial
The percentage of lesioned area covered by granulation tissue after 4 weeks is significantly higher in patients treated with Vulnamin®
Reduction of ulcer areas after 4 weeks
Lesion score
Patients treated with Vulnamin show a faster improvement for all the items that composed the score
Healing Time
Vulnamin reduced the time to healing
